In recent years, a series of clinical studies [5–10] have reported that high circulating GDF15 levels are an independent predictive factor for several cardiovascular diseases in patients with atherosclerosis and acute coronary syndrome, and that investigating the levels of GDF15 could improve risk prediction beyond traditional risk factors and biochemical indicators. This evidence concerns the gene GDF15 and atherosclerosis.